SCHEMBL27404455

SCHEMBL27404455

CC(=O)O[C@@H]1COC(C)(C)O1

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.41
CA2 P00918 3/20 0.37
L3MBTL1 Q9Y468 1/20 0.34
POLB P06746 1/20 0.32
HCRTR2 O43614 3/20 0.32
HCRTR1 O43613 2/20 0.32
OGA O60502 1/20 0.32
CA1 P00915 1/20 0.31
TMEM97 Q5BJF2 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
ALDH1A1 P00352 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15151257 1.00 TSHR (0.41) TSHRCA2L3MBTL1POLBHCRTR2
SCHEMBL27427939 1.00 TSHR (0.41) TSHRCA2L3MBTL1POLBHCRTR2
SCHEMBL28912789 0.87 CA2 (0.37) CA2L3MBTL1HCRTR2HCRTR1CA1
SCHEMBL5597174 0.85 L3MBTL1 (0.36) CA2L3MBTL1HCRTR2HCRTR1TMEM97
SCHEMBL10374015 0.83 CA2 (0.35) TSHRCA2L3MBTL1HCRTR2HCRTR1
SCHEMBL1876643 0.82 TSHR (0.38) TSHRCA2
SCHEMBL10965421 0.82 L3MBTL1 (0.37) CA2L3MBTL1HCRTR2HCRTR1CA1
SCHEMBL24082907 0.80 CA2 (0.37) CA2L3MBTL1HCRTR2HCRTR1TMEM97
SCHEMBL10716770 0.80 ALDH1A1 (0.41) CA2L3MBTL1ALDH1A1
SCHEMBL3683016 0.80 MAPT (0.33) CA2L3MBTL1ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1222519-C Reverse hydroxamate inhibitors of matrix metalloproteinases ABBOTT LAB (US) 2005-10-12 CN disclosed
CN-1339032-A Reverse hydroxamate inhibitors of matrix metalloproteinases ABBOTT LAB (US) 2002-03-06 CN disclosed
CN-1085546-A Aminediol protease inhibitors SQUIBB & SONS INC (US) 1994-04-20 CN disclosed